Detalhe da pesquisa
1.
Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer.
Ann Oncol
; 35(1): 98-106, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871701
2.
[Results of subinguinal microsurgical varicocelectomy]. / Résultats des cures de varicocèles microchirurgicales sous-inguinales.
Prog Urol
; 33(10): 481-487, 2023 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-37537033
3.
Ureteropelvic junction obstruction and renal calculi: Simultaneous treatment by robot-assisted laparoscopic pyeloplasty and transcutaneous retrograde flexible ureteroscopy. Technique description and early outcomes.
Prog Urol
; 33(5): 279-284, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36792487
4.
[Pathological pelvic lymph node involvement in muscle-invasive bladder cancer patients treated with radical cystectomy: A narrative review]. / Envahissement ganglionnaire pelvien anatomopathologique après cystectomie totale pour le traitement des tumeurs de vessie infiltrant le muscle : une revue narrative de la littérature.
Prog Urol
; 33(3): 145-154, 2023 Mar.
Artigo
em Francês
| MEDLINE | ID: mdl-36604248
5.
Photodynamic cystoscopy for bladder cancer diagnosis and for NMIBC follow-up: An overview of systematic reviews and meta-analyses.
Prog Urol
; 33(6): 307-318, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088584
6.
[Early detection of prostate cancer: Towards a new paradigm?] / Détection précoce du cancer de la prostate : vers un nouveau paradigme ?
Prog Urol
; 33(15-16): 956-965, 2023 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-37805291
7.
Biochemical relapse predictive factors in patients with lymph node metastases during radical prostatectomy.
Prog Urol
; 32(16): 1462-1468, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35941008
8.
French AFU Cancer Committee Guidelines - Update 2022-2024: penile cancer.
Prog Urol
; 32(15): 1010-1039, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400476
9.
French AFU Cancer Committee Guidelines Update 2022-2024: Adrenal tumor - Assessment of an adrenal incidetaloma and oncological management.
Prog Urol
; 32(15): 1040-1065, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400477
10.
French AFU Cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer.
Prog Urol
; 32(15): 1066-1101, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400478
11.
[Guidelines from the cancer (CC-AFU) and infection disease (CI-AFU) committees of the French Association of Urology for the management of adverse events and complications of BCG]. / Recommandations des Comités de cancérologie (CC-AFU) et d'infectiologie (CI-AFU) de l'Association française d'urologie pour la prise en charge effets indésirables et complications du BCG.
Prog Urol
; 32(3): 165-176, 2022 Mar.
Artigo
em Francês
| MEDLINE | ID: mdl-35125314
12.
[DNA repair gene alterations testing in prostate cancer : A practical update by the prostate cancer committee of the french association of urology]. / Recherche d'altérations des gènes de réparation de l'ADN dans le cancer de la prostate : mise au point pratique du Comité de cancérologie de l'association française d'urologie.
Prog Urol
; 32(3): 155-164, 2022 Mar.
Artigo
em Francês
| MEDLINE | ID: mdl-35125317
13.
[Intravesical adjuvant regimen of epitubicin for intermediate risk NMIBC: Feasability study from CC-AFU vessie]. / Instauration du traitement adjuvant endovésical par épirubicine des tumeurs de vessie n'infiltrant pas le muscle : premier retour national d'expérience du CC-AFU vessie.
Prog Urol
; 32(5): 326-331, 2022 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-35151544
14.
[Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer]. / Recommandations du Comité de cancérologie de l'Association Française d'Urologie (CC-AFU) pour la bonne pratique des instillations intravésicales de mitomycine C, d'épirubicine et de BCG pour le traitement des tumeurs de la vessie n'infiltrant pas le muscle (TVNIM).
Prog Urol
; 32(5): 299-311, 2022 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-35151545
15.
French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC).
Prog Urol
; 32(15): 1102-1140, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400479
16.
French AFU Cancer Committee Guidelines - Update 2022-2024: Muscle-Invasive Bladder Cancer (MIBC).
Prog Urol
; 32(15): 1141-1163, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400480
17.
French AFU Cancer Committee Guidelines - Update 2022-2024: Upper urinary tract urothelial cancer (UTUC).
Prog Urol
; 32(15): 1164-1194, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400481
18.
[Recent advances in the management of localized high-risk prostate cancer: An update by the Prostate Cancer Committee of the French Association of Urology]. / Avancées récentes dans la prise en charge du cancer de la prostate localisé à haut risque : mise au point par le Comité Prostate de l'Association française d'urologie.
Prog Urol
; 32(10): 623-634, 2022 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-35644728
19.
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease.
Prog Urol
; 32(15): 1275-1372, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400483
20.
French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer.
Prog Urol
; 32(15): 1195-1274, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400482